The many faces of regulatory T cells

Inmunologia

Volumn 26, Issue 1, 2007, Pages 29-41

  Casares, Noelia ^a   Gil Guerrero, L ^a   Melero, I ^a   Dubrot, J ^a   Lasarte, J J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Autoimmunity; Regulatory T cell; Tumor immunity

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2; PEPTIDE DERIVATIVE; PROTEOME; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TUMOR VACCINE;

ANTIGEN FUNCTION; AUTOIMMUNITY; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SURFACE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TAXONOMY; THYMUS; TUMOR IMMUNITY; VIRUS INFECTION;

EID: 34347373935     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. + regulatory T cells. Immunol Lett 2005;97:189-192.
2. Wickelgren I. Immunology. Policing the immune system. Science 2004;306:596-599.
3. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003;3:253-257.
4. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
5. - regulatory T cells. Proc Natl Acad Sci U S A 2002;99:13031-13036.
6. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-142.
7. Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, et al. Role of LAG-3 in regulatory T cells. Immunity 2004;21:503-513.
8. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
9. - regulatory T cells. J Immunol 2006;176:4748-4756.
10. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280.
11. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
12. Itoh Y, Hemmer B, Martin R, Germain RN. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events. J Immunol 1999;162:2073-2080.
13. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
14. Fontenot JD, Dooley JL, Farr AG, Rudensky AY. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005;202:901-906.
15. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, Haas DW, Unutmaz D. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004;2:E198.
16. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
17. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 2002;195:603-616.
18. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192:1213-1222.
19. + T cells by human mature autologous dendritic cells. Eur J Immunol 2004;34:762-772.
20. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006;25:195-201.
21. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303-310.
22. Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J Immunol 2004;172:34-39.
23. + Regulatory T Cells. J Immunol 2007;178:1542-1552.
24. Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 2004;101:10398-10403.
25. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004;4:665-674.
26. + T cell numbers. J Immunol 2002;169:4850-4860.
27. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2R,-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002;17:167-178.
28. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, Virzi E, Rescigno M, et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2001;2:882-888.
29. + CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 2006;107:2409-2414.
30. + T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 2005;28:120-128.
31. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
32. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001;194:629-644.
33. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137-161.
34. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
35. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, Khazaie K. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc Natl Acad Sci U S A 2005;102:419-424.
36. + T cells through TGF-β-TGF-β, receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A 2003;100:10878-10883.
37. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338-344.
38. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002;196:247-253.
39. + T helper cells. J Exp Med 2002;196:255-260.
40. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000;164:183-190.
41. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004;21:589-601.
42. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005;174:1783-1786.
43. + T cells selectively kill B lymphocytes. Blood 2006;107:3925-3932.
44. Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002;129:263-276.
45. + T regulatory cells in human neonatal T cell responses to environmental antigens/allergens. J Immunol 2004;173:3084-3092.
46. Coates FT, Duncan FJ, Colvin BL, Wang Z, Zahorchak AF, Shufesky WJ, Morelli AE, et al. In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation 2004;77:1080-1089.
47. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 2002;80:477-483.
48. + regulatory T cells in the steady state. J Exp Med 2003;198:737-746.
49. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003;198:235-247.
50. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000;30:1538-1543.
51. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
52. - T cells to acquire regulatory cell function. Blood 2003;101:5076-5083.
53. + T cells resulting in a failure to lyse tumor cells. Blood 1999;93:1634-1642.
54. Vlad G, Cortesini R, Suciu-Foca N. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 2005;174:5907-5914.
55. Becker C, Stoll S, Bopp T, Schmitt E, Jonuleit H. Regulatory T cells: present facts and future hopes. Med Microbiol Immunol (Berl) 2006;195:113-124.
56. + regulatory T cells. J Immunol 2004;172:5986-5993.
57. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73.
58. + regulatory T cells. Nat Immunol 2003;4:330-336.
59. + regulatory T cells. Int Immunol 2004;16:1643-1656.
60. - T cells. J Clin Invest 2003;112:1437-1443.
61. Wang J, Ioan-Facsinay A, Van der Voort EH, Huizinga T, Toes R. Eur J Immunol 2007;37:129-138.
62. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-352.
63. Grant C, Oh U, Fugo K, Takenouchi N, Griffith C, Yao K, Newhook TE, et al. Foxp3 represses retroviral transcription by targeting both NF-ÎB and CREB pathways. PLoS Pathog 2006;2:e33.
64. Rudensky AY, Gavin M, Zheng Y. Foxp3 and NFAT: partners in tolerance. Cell 2006;126:253-256.
65. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, et al. Foxp3 controls regulatory T cell function through cooperation with NFAT. Cell 2006;126:375-387.
66. Stroud JC, Wu Y, Bates DL, Han A, Nowick K, Paabo S, Tong H, et al. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 2006;14.159-166.
67. Melero I, Arina A, Chen L. The many sounds of T lymphocyte silence. Immunol Res 2005;33:135-147.
68. Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab Invest 1976;34:550-557.
69. Penhale WJ, Farmer A, Urbaniak SJ, Irvine WJ. Susceptibility of inbred rat strains to experimental thyroiditis: quantitation of thyroglobulin-binding cells and assessment of T-cell function in susceptible and non-susceptible strains. Clin Exp Immunol 1975;19:179-191.
70. Ziegler SF. Foxp3: of mice and men. Annu Rev Immunol 2006;24:209-226.
71. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 2002;196:1079-1090.
72. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431-440.
73. Robinson DS, Larche M, Durham SR. Tregs and allergic disease. J Clin Invest 2004;114:1389-1397.
74. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 1985;161:72-87.
75. + T cells. J Immunol 1999;162:5309-5316.
76. Sakaguchi N, Miyai K, Sakaguchi S. Ionizing radiation and autoimmunity. Induction of autoimmune disease in mice by high dose fractionated total lymphoid irradiation and its prevention by inoculating normal T cells. J Immunol 1994;152:2586-2595.
77. Sakaguchi S. Animal models of autoimmunity and their relevance to human diseases. Curr Opin Immunol 2000;12:684-690.
78. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002;298:850-854.
79. Overwijk WW, Restifo NP. Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other". Crit Rev Immunol 2000;20:433-450.
80. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6:295-307.
81. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 2004;16:81-88.
82. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562.
83. Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 2001;19:565-594.
84. + T cell activation and experimental autoimmune encephalomyelitis. J Immunol 2004;172:4686-4690.
85. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-5218.
86. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-832.
87. + regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002;32:3267-3275.
88. + T cell-mediated suppression by dendritic cells. Science 2003;299:1033-1036.
89. Yang Y, Huang CT, Huang X, Pardoll DM. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 2004;5:508-515.
90. + T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 2003;171:5931-5939.
91. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 1999;59:3128-3133.
92. + regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun 2002;2:1.
93. + regulatory T cells. J Exp Med 2005;202:885-891.
94. + T Cell Homeostasis. J Immunol 2007;178:1251-1255.
95. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949.
96. + T cells. Adv Immunol 2003;81:331-371.
97. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-2761.
98. + regulatory T cells. J Immunol 2005;174:2661-2670.
99. + suppressor lymphocytes in the circulation of patients immunized against melanoma antigens. J Immunother 2003;26:85-93.
100. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001;61:4766-4772.
101. Tanchot C, Vasseur F, Pontoux C, Garcia C, Sarukhan A. Immune regulation by self-reactive T cells is antigen specific. J Immunol 2004;172:4285-4291.
102. +CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004;173:1444-1453.
103. + regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res 2002;62:5267-5272.
104. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003;9:606-612.
105. Terabe M, Berzofsky JA. Immunoregulatory T cells in tumor immunity. Curr Opin Immunol 2004;16:157-162.
106. + T cell function by Friend virus-induced regulatory T cells. J Immunol 2006;176:3342-3349.
107. + T cells during chronic hepatitis C virus infection. J Virol 2005;79:7860-7867.
108. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-1071.
109. + T cells during persistent hepatitis C virus infection. J Virol 2005;79:7852-7859.
110. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006;177:739-747.
111. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004;78:2454-2459.
112. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004;200:331-343.
113. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004;104:3249-3256.
114. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, Schacker T, Picker LJ, et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006;193:703-712.
115. + T cells can prevent murine AIDS progression. J Immunol 2004;172:4917-4925.
116. + T regulatory cells. J Immunol 2004;172:4752-4761.
117. + helper and regulatory T cells elicited by in vitro peptide stimulation. Cancer Res 2005;65:1577-1586.
118. + T cells. J Immunol 2004;173:5008-5020.
119. Gilboa E. The risk of autoimmunity associated with tumor immunotherapy. Nat Immunol 2001;2:789-792.
120. + T cell immunity against B16 melanoma. J Immunol 2003;171:5940-5947.
121. Warger T, Osterloh P, Rechtsteiner G, Fassbender M, Heib V, Schmid B, Schmitt E, et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 2006;108:544-550.
122. +CD25high regulatory T cells in human pregnancy. J Reprod Immunol 2005;65:111-120.
123. Rouse BT, Suvas S. Regulatory cells and infectious agents: detentes cordiale and contraire. J Immunol 2004;173:2211-2215.
124. + regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004;172:4123-4132.